Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

5 May 2011 07:00

RNS Number : 9726F
Tarsus Group PLC
05 May 2011
 



 

5 May 2011

 

 

TARSUS GROUP plc

 

Interim Management Statement

 

On track for the full year - forward bookings accelerating

 

Tarsus Group Plc ("Tarsus" or "the Group"), the international business-to-business media group, is today publishing its Interim Management Statement relating to the period from the publication of its Preliminary Results on 7 March 2011 to 5 May 2011.

 

Trading Performance

 

Trading for the period and forward bookings for the full year have been positive and remain in-line with the Board's expectations. A summary of major developments includes:

 

§ US

 

As previously indicated the February 2011 Off-Price Show in Las Vegas performed well with revenues up 10%. The broadening of the offer to retailers by the inclusion of footwear and accessories has been a major factor in this division's success. Bookings for the August show are good.

 

The Medical division demonstrated good growth driven by our education programmes including those now delivered online. There have been a number of events in the period the largest of which was the April Orlando event which produced revenues 2% ahead of last year. This division continues to grow its total revenues at a double digit rate.

 

§ France

 

The trends that we experienced in the second half of 2010 continued into the first 4 months of 2011 with the portfolio stabilising. Mod'amont, our largest event in the period, was the same size as its February 2010 edition and was well received by our customers with a good increase in visitors. The smaller IT and services exhibitions in April produced revenues behind last year's editions but, encouragingly for the future, grew their attendances by 8%.

 

§ Emerging Markets

 

Our Emerging Markets business continued to gain momentum with strong revenue growth. In the period, we held a number of events in the Middle East which all demonstrated good performances and, very encouragingly, across the board attendances at these events were well ahead of their previous editions.

 

Financial Position

 

There have been no significant changes to the financial position of the Group since the publication of the Preliminary Results on 7 March 2011.

 

Outlook

 

We remain committed to our long term strategy of increasing our exposure to Emerging Markets (Project 50/13) and driving organic growth within the business. Activity in the exhibition market generally is picking up and we are seeing an increase in M&A opportunities which fit our criteria.

 

Within each two-year cycle, odd years are by far the larger in profit terms for the Group as they contain both Labelexpo Europe (in September) and the Dubai Airshow (in November). Bookings for Labelexpo Europe continue to improve and are now tracking over 10% up on its previous edition. The Dubai Airshow bookings are tracking in-line with its previous edition.

 

As in previous years, the Group's revenues remain heavily second-half weighted. Forward bookings continue to accelerate and now stand at 75% of anticipated full year revenues compared with 67% at the same time in 2010 (as adjusted for biennial events).

 

 

 

 

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

 

Media:

 

Madano Partnership

Matthew Moth 020 7593 4000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDKQDPCBKDPPK
Date   Source Headline
9th May 20134:53 pmRNSBlocklisting Interim Review
30th Apr 20135:56 pmRNSHolding(s) in Company
30th Apr 20135:09 pmRNSTotal Voting Rights
30th Apr 20135:09 pmRNSDirector/PDMR Shareholding
17th Apr 20137:15 amRNSAnnual Financial Report
15th Apr 20134:55 pmRNSDirector/PDMR Shareholding
10th Apr 20132:36 pmRNSDirector/PDMR Shareholding
3rd Apr 20135:15 pmRNSDirector/PDMR Shareholding
3rd Apr 201311:49 amRNSTotal Voting Rights and Capital
18th Mar 20136:00 pmRNSHolding(s) in Company
8th Mar 20135:22 pmRNSDirector/PDMR Shareholding
6th Mar 20137:00 amRNSFinal Results
1st Mar 20137:00 amRNSCompletion of Indonesian Acquisition
19th Feb 201310:12 amRNSNotice of Results
30th Jan 20137:30 amRNSAdditional Listing
16th Jan 20137:00 amRNSIndonesian Acquisition
14th Jan 20134:25 pmRNSDirector Declaration
7th Jan 20137:00 amRNSTrading Statement
2nd Jan 20135:09 pmRNSDirector/PDMR Shareholding
20th Dec 20124:00 pmRNSScrip dividend circular
18th Dec 20127:00 amRNSBoard Changes: Non-executive director roles
17th Dec 20127:00 amRNSCompletion of joint venture with GZ Auto
30th Nov 20122:37 pmRNSTotal Voting Rights
15th Nov 20127:00 amRNSInterim Management Statement
9th Nov 20123:25 pmRNSBlocklisting Interim Review
6th Nov 20122:23 pmRNSCompletion of Acquisition
31st Oct 20124:18 pmRNSTotal Voting Rights
25th Oct 20127:00 amRNSAcquisition
17th Oct 201212:08 pmRNSApplication for Admission
28th Sep 20123:25 pmRNSTotal Voting Rights
11th Sep 20121:45 pmRNSInterim Financial Statements 2012
7th Sep 20127:00 amRNSSite Visit
5th Sep 20124:40 pmRNSDirector/PDMR Shareholding
31st Aug 20122:39 pmRNSTotal Voting Rights
20th Aug 20124:13 pmRNSDirector/PDMR Shareholding
25th Jul 20127:00 amRNSHalf Yearly Report
12th Jul 20127:00 amRNSApplication for Admission
6th Jul 201210:08 amRNSNotice of Results
4th Jul 20121:41 pmRNSResult of AGM
29th Jun 20127:00 amRNSPre-Close Trading Statement
28th Jun 20124:40 pmRNSSecond Price Monitoring Extn
28th Jun 20124:35 pmRNSPrice Monitoring Extension
18th Jun 20127:00 amRNSCirc re. Scrip Dividend
15th May 20127:00 amRNSInterim Management Statement
9th May 20124:11 pmRNSBlocklisting Six Monthly Return
9th May 20124:05 pmRNSAnnual Information Update
3rd May 20125:06 pmRNSDirector/PDMR Shareholding
30th Apr 20124:53 pmRNSTotal Voting Rights
25th Apr 20123:42 pmRNSAnnual Report & Accounts and Notice of 2012 AGM
25th Apr 20127:00 amRNSChinese Joint Venture

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.